← Evidence map

ArticleSkin health and disease2024

Abrocitinib may improve itch and quality of life in patients with itch-dominant atopic dermatitis.

Jonathan I Silverberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
2026
this papertrialcites it

5 trials

Full record →Abstract, authors, funding and every citing paper · PMID 39104653